Anthropometry (2)
- height - Subject's height (phv00426794.v1.p1)
- weight - Subject's weight (phv00426795.v1.p1)
Biomarkers (1)
- hypertension - Hypertension at enrollment (phv00426796.v1.p1)
Demographics (4)
- age - Age at enrollment (phv00426789.v1.p1)
- age_diagnosis - Age at AF diagnosis (phv00426790.v1.p1)
- sex - Gender of participant (phv00426791.v1.p1)
- SEX - Sex/gender of subject (phv00572184.v1.p1)
Disease Events (4)
- diabetes - Diabetes at enrollment (phv00426797.v1.p1)
- heart_failure - Heart failure at enrollment (phv00426798.v1.p1)
- myocardial_infarction - Myocardial infarction at enrollment (phv00426799.v1.p1)
- valvular_heart_disease - Valvular heart disease at enrollment (phv00426800.v1.p1)
Race and Ethnicity (2)
- ethnicity - Ethnicity of participant (phv00426793.v1.p1)
- race - Race of participant (phv00426792.v1.p1)
Other (18)
- af_status - AF status (phv00426788.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00426806.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00426805.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00426783.v1.p1)
- EF_ever_50 - EF ever <50% (phv00426803.v1.p1)
- Funding_Source - Project funding source (phv00426809.v1.p1)
- IS_TUMOR - Tumor status (phv00426807.v1.p1)
- LA_size_echo - LA size by echo (closest to enrollment) (phv00426801.v1.p1)
- LVEF_echo - LVEF by echo (closest to enrollment) (phv00426802.v1.p1)
- SAMPLE_ID - Sample ID (phv00426804.v1.p1)
- SAMPLE_ID - Sample ID (phv00426786.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00426808.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00426812.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00426787.v1.p1)
- SUBJECT_ID - Subject ID (phv00426782.v1.p1)
- SUBJECT_ID - Subject ID (phv00426785.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00426810.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00426811.v1.p1)